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MaOBJECTIVES The purpose of this study was to establish a scoring system to evaluate the risk of side branch (SB)
occlusion in patients undergoing coronary bifurcation intervention.
BACKGROUND The risk of SB occlusion is the most important consideration affecting the selection of an optimal
intervention strategy.
METHODS Atotal of 1,545consecutivepatientsundergoingpercutaneouscoronary intervention forbifurcation lesions (1,601
lesions treated with a single stent technique or main vessel [MV] stenting ﬁrst strategy) were studied. A total of 1,200 lesions
were used to construct the risk model and score system, and 401 lesions were used to validate the model. A multivariable risk
score (RESOLVE [Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion]) was constructed with incre-
mental weights attributed to each component variable according to its estimated coefﬁcients. SB occlusion after MV stenting
was deﬁned as any decrease in Thrombolysis in Myocardial Infarction ﬂow grade or absence of ﬂow in SB after MV stenting.
RESULTS SB occlusion occurred in 118 (7.37%) of 1,601 bifurcation lesions. In multivariable analyses, 6 variables were
independently associated with the risk of SB occlusion (model C-statistic ¼ 0.80 [95% conﬁdence interval: 0.75 to 0.85]
with good calibration). For the 401 lesions included in the validation cohort, the RESOLVE score had a C-statistic of 0.77
(95% conﬁdence interval: 0.69 to 0.86), with good calibration. SB occlusion rates in the validation cohort increased
signiﬁcantly across different risk groups, from 0.0% in the low-risk group, to 3.8% in the intermediate-risk group, and to
19.8% in the high-risk group (p < 0.001).
CONCLUSIONS The RESOLVE score, a novel angiographic risk stratiﬁcation tool, can help identify patients at risk for
SB occlusion during bifurcation intervention. (J Am Coll Cardiol Intv 2015;8:39–46) © 2015 by the American College of
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FIGURE 1 Flowchart of the R
PCI ¼ percutaneous coronary in
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CI = conﬁdence interval
HL = Hosmer-Lemeshow test
MV = main vessel
PCI = percutaneous coronary
intervention
QCA = quantitative coronary
angiography
SB = side branch
TIMI = Thrombolysis In
Myocardial Infarction
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40respect to clinical outcomes (1–4). However,
SB occlusion after main vessel (MV) stenting
is an infrequent but serious procedural
complication for the provisional approach.
SB occlusion can result in vessel closure and
ischemia, with clinically-signiﬁcant myocar-
dial infarction and even death depending
upon the size of the SB (and the myocardial
territory subtended by it) (5,6). Thus, particu-
larly for large SB with signiﬁcant disease,
the optimal intervention strategy remains
controversial.SEE PAGE 47Clinical studies of bifurcation PCI have primarily
attempted to determine which strategy (e.g., provi-
sional vs. 2-stent) is most optimal. However, it can be
argued that no single approach should be the default
strategy in all patients with bifurcation lesions (7).
For example, the contribution of speciﬁc bifurcation
anatomy in determining the optimal technique for
bifurcation PCI has been recently examined (8).
Ideally, the decision-making regarding the best
strategy to treat bifurcation lesions should ultimately
be based on the individual characteristics of the
treated patient/lesion affecting the probability of SB
occlusion.
The risk of SB occlusion is the most important
factor affecting the selection of an optimal interven-
tion strategy in coronary bifurcation intervention.
Previous studies have reported that the risk of SB
occlusion could be affected by numerous factors like
bifurcation lesion anatomy and the PCI procedureESOLVE Study
tervention; SB ¼ side branch.(6,9–11). However, the potential contributions of
angiographic and PCI procedural indexes to SB oc-
clusion have not been fully elucidated. Clinical pre-
diction models involving clinical, angiographic, and
PCI procedural indexes may, therefore, be helpful for
medical decision making. Accordingly, this study was
designed to establish a novel score system, RESOLVE
(Risk prEdiction of Side branch OccLusion in coronary
bifurcation interVEntion), to evaluate the risk of SB
occlusion in coronary bifurcation intervention.
METHODS
STUDY POPULATION. From January 2012 to July 2012,
a cohort of 7,007 consecutive patients underwent PCI
at Fuwai Hospital in Beijing, China. For the present
study, speciﬁc inclusion criteria were: 1) patients with
a coronary bifurcation lesion (deﬁned as a coronary
artery narrowing occurring adjacent to or involving
the origin of a signiﬁcant SB) undergoing PCI; and
2) patients with bifurcation lesion consisting of a
signiﬁcant SB conﬁrmed by the treating physician and
the core laboratory. Selection of SB was not based
on the reference diameter of SB to avoid neglecting
small SB that could have important clinical signiﬁ-
cance. The criteria for a signiﬁcant SB were based
upon those deﬁned by the European Bifurcation Club
(12); that is, a branch that the operator would not
want to lose in the global context of a particular
patient (symptoms, location of ischemia, viability,
collateralizing vessel, left ventricular function and
so on). The reference diameter of SB was principally
$1.5 mm. Patients undergoing elective SB stenting
before MV stenting were excluded. Among the 7,007
patients, 5,172 patients without bifurcation lesions
and 290 patients with bifurcation lesions undergoing
elective SB stenting were excluded. A total of 1,545
patients with 1,601 bifurcation lesions that met all
the inclusion criteria and had no exclusion criteria
were included in this study (Figure 1). PCI procedure
and periprocedural medications were based on the
operator’s discretion and current guidelines (Online
Appendix).
The ethics committee of the Cardiovascular Insti-
tute and Fuwai Hospital approved this study.
DATA COLLECTION AND QUANTITATIVE CORONARY
ANGIOGRAPHY. Clinical data were obtained through a
review of the medical records. All baseline and pro-
cedural cineangiograms were reviewed and analyzed
by an independent core laboratory (for details, please
see the Online Appendix). Blood sampling and cardiac
enzyme measurement are also detailed in the Online
Appendix.
FIGURE 2 Schematic Diagram of Quantitative Coronary Angiographic Analysis
Bifurcation lesions were analyzed as 4 segments: the proximal MV segment, the distal MV
segment, the SB segment, and the bifurcation core segment. MV ¼ main vessel; SB ¼ side
branch.
TABLE 1 Baseline Characteristics
No SB Occlusion
(n ¼ 1,431)
SB Occlusion
(n ¼ 114) p Value
Age (yrs) 58.1  9.9 57.8  11.1 0.80
Male 1,101 (76.9) 93 (81.6) 0.26
BMI (kg/m2) 26.1  3.1 26.1  3.4 1.00
Diabetes mellitus 401 (28.0) 31 (27.2) 0.85
Hypertension 894 (62.5) 71 (62.3) 0.96
Hyperlipemia 1,143 (79.9) 94 (82.5) 0.52
Myocardial infarction in 1 month 269 (18.8) 31 (27.2) 0.03
Emergency PCI 41 (2.9) 8 (7.1) 0.01
Unstable angina 664 (46.4) 42 (36.8) 0.05
LVEF (%) 61.9  8.5 63.2  7.0 0.09
Previous myocardial infarction
(>1 month)
231 (16.1) 25 (21.9) 0.11
Previous PCI 244 (17.1) 23 (20.2) 0.40
Previous CABG 5 (0.35) 0 (0) 1.00
Previous stroke 145 (10.1) 16 (14.0) 0.19
Family history of CAD 259 (18.1) 23 (20.2) 0.58
Previous peripheral vascular disease 217 (15.2) 18 (15.8) 0.86
Smoking history 525 (36.7) 50 (43.9) 0.13
Values are mean  SD or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass grafting; CAD ¼ coronary artery
disease; LVEF ¼ left ventricular ejection fraction; PCI ¼ percutaneous coronary intervention;
SB ¼ side branch.
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41Quantitative coronary angiography (QCA) was
performed using standard quantitative analyses and
deﬁnitions (13). Angiograms obtained at baseline and
after pre-dilation were analyzed with a computer-
based system dedicated to bifurcation analysis (Qan-
gio XA, version 7.3, Medis, Leiden, the Netherlands).
We obtained quantitative angiographic measure-
ments of the 4 segments of the bifurcation lesion: the
proximal MV segment, the distal MV segment, the SB
segment, and the bifurcation core segment (Figure 2).
Bifurcation core was deﬁned as the central part of the
bifurcation, which begins where the common vessel
starts to split into 2 branches and ends at the carinal
point (14), the area of which is calculated by the
Qangio XA software. We also obtained the bifurcation
angle (BA) (the angle between the distal MV and the
SB) from the analysis system.
In addition to the intrinsic data outputted by the
QCA system, another variable was derived based on
the raw QCA data: the diameter ratio between MV/SB
([reference diameter of proximal MV þ reference
diameter of distal MV] ⁄ 2 [reference diameter of SB]),
which is a parameter reﬂecting the relative plaque
shift burden from MV to SB.
STATISTICAL METHODS AND SCORE DETERMINATION.
Statistical methods are detailed in the Online
Appendix. The database was divided into 2 subsets
by procedural chronological order: a developmental
dataset of 1,200 lesions that served to construct the
risk model, and a validation subset of 401 lesions to
test and validate the model. The multivariable model
was built by stepwise variable selection with the same
entry and exit criteria as in the univariable analyses.
The score was then derived by attributing integer
numbers to the variables retained in the multivariable
model. Additionally, the scoring system was then
used to deﬁne 3 risk groups (low, intermediate, and
high risk). All p values were 2-tailed, and a p value
<0.05 was considered statistically signiﬁcant. All
analyses were performed with the SAS version 9.3
system (SAS Institute, Cary, North Carolina).
RESULTS
PATIENT, LESION, AND PROCEDURAL CHARACTERISTICS.
SB occlusion occurred in 118 (7.37%) of 1,601 bifur-
cation lesions treated with a single stent technique
or MV stenting ﬁrst strategy. Of SB occlusions, total
occlusion occurred in 83 (70.3%) of lesions and a
decrease in TIMI (Thrombolysis In Myocardial In-
farction) ﬂow occurred in 35 (29.7%) lesions. Blood
ﬂow in SB was restored spontaneously in 12 (10.2%)
lesions and by SB intervention in 8 (6.8%) lesionsof 118 occluded SB. In total, 98 (83.0%) lesions
occluded permanently. SB occlusion was signiﬁcantly
associated with periprocedural myocardial infarction
(6.1% vs. 1.3%, p < 0.001) (Online Table 1).
The overall patient characteristics are shown in
Table 1. Except for the rate of myocardial infarction
at 1 month and emergency PCI, all baseline charac-
teristics were not signiﬁcantly different between the
2 groups. Lesion and procedural characteristics are
TABLE 2 Lesion and Procedural Characteristics
No SB Occlusion
(n ¼ 1,483)
SB Occlusion
(n ¼ 118) p Value
Lesion characteristics
Coronary distribution 0.82
Right dominant coronary 1,369 (92.3) 107 (90.7)
Left dominant coronary 73 (4.9) 7 (5.9)
Codominant coronary 41 (2.8) 4 (3.4)
Location of bifurcation 0.01
Left main bifurcation 38 (2.5) 0 (0)
LAD/diagonal 830 (56.0) 54 (45.8)
LCX/OM 326 (22.0) 29 (24.6)
RCA bifurcation 289 (19.5) 35 (29.7)
Medina classiﬁcation <0.001
1, 0, 0 472 (31.8) 27 (22.9)
0, 1, 0 457 (30.8) 12 (10.2)
1, 1, 0 211 (14.2) 14 (11.9)
1, 1, 1 138 (9.3) 31 (26.3)
0, 0, 1 6 (0.4) 1 (0.8)
1, 0, 1 118 (8.0) 18 (15.3)
0, 1, 1 81 (5.5) 15 (12.7)
True bifurcation 344 (23.2) 65 (55.1) <0.001
MV
Plaque located at the same side of SB 497 (33.5) 61 (51.7) <0.001
Moderate–severe calciﬁcation 68 (4.6) 7 (5.9) 0.51
Moderate–severe angulation 795 (53.6) 56 (47.5) 0.20
Thrombus containing 69 (4.7) 11 (9.3) 0.04
Pre-procedural TIMI ﬂow grade <0.001
TIMI 1 59 (4.0) 16 (13.6)
TIMI 2 153 (10.3) 15 (12.7)
TIMI 3 1,271 (85.7) 87 (73.7)
Irregular plaque 76 (5.1) 18 (15.3) <0.001
SB
Moderate–severe calciﬁcation 4 (0.3) 0 (0) 1.00
Moderate–severe angulation 76 (5.1) 6 (5.1) 1.00
Thrombus containing 3 (0.2) 0 (0) 1.00
Pre-procedural TIMI ﬂow grade <0.001
TIMI 1 18 (1.2) 1 (0.9)
TIMI 2 20 (1.4) 9 (7.6)
TIMI 3 1,445 (97.4) 108 (91.5)
Irregular plaque 20 (1.4) 3 (2.5) 0.24
Continued on the next page
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42presented in Table 2. Among lesion characteristics,
location of bifurcation, Medina classiﬁcation, and
distribution of plaque differed signiﬁcantly between
the 2 study groups. Among procedural characteristics,
all data except the rate of SB pre-dilation were
signiﬁcantly different between the 2 groups. QCA
data are presented in Table 3. There were signiﬁcant
differences between the 2 groups in reference diam-
eter of all 4 parts of the bifurcation. However, with
respect to length, only the lesion length of bifurcation
core was signiﬁcantly different between the 2 groups.
The diameter ratio between MV/SB in the SB occlu-
sion group (1.6  0.3) was signiﬁcantly higher than
in the no SB occlusion group (1.4  0.3) (p < 0.001).Additional analyses of patient and lesion char-
acteristics in the low BA group (BA <50) and
high BA group (BA $50) are presented in Online
Tables 2 to 5.
THE RESOLVE RISK MODEL AND RESOLVE RISK SCORE.
After univariable and multivariable selection, 5 pri-
mary angiographic variables (plaque distribution,
MV TIMI ﬂow grade before stenting, pre-procedural
diameter stenosis of bifurcation core, bifurcation
angle, and diameter stenosis of SB before MV stent-
ing) and 1 derived variable (diameter ratio between
MV/SB) remained independently associated with the
risk of SB occlusion. There was little correlation
apparent between these variables; the variance in-
ﬂation factor showed an absence of multicollinearity
among variables in the model (shown in Online
Table 6). Within the derivation sample, the C-statistic
for this model was 0.80 (95% conﬁdence interval [CI]:
0.75 to 0.85) (Figure 3A), and excellent calibration was
observed (Hosmer-Lemeshow [HL] p ¼ 1.00).
The scores attributed to each variable according
to the estimated coefﬁcients from the derivation
dataset are shown in Table 4. The risks of SB occlusion
associated with each point are presented in Online
Table 7. The C-statistic for the risk score was only
slightly worse than that of the original model: 0.76
(95% CI: 0.71 to 0.82; HL p ¼ 0.12) (Figure 3A).
RESOLVE scores range from 0 to 43. The inter-
quartile range and the frequency distribution of each
variable across quartiles of RESOLVE score are dis-
played in Online Table 8. As shown in the table, event
rates in the derivation cohort across quartiles of
RESOLVE score were: 1.0% in quartile I (RESOLVE
score: 0 to 2); 3.9% in quartile II (RESOLVE score: 3 to
6); 3.6% in quartile III (RESOLVE score: 7 to 9); and
17.5% in quartile IV (RESOLVE score: $10) (p < 0.001).
The odds of SB occlusion were 0.049 (95% CI: 0.007
to 0.356) for quartile I versus quartile IV, 0.193 (95%
CI: 0.110 to 0.338) for quartile II versus quartile IV, and
0.175 (95% CI: 0.092 to 0.333) for quartile III versus
quartile IV. There were no differences in SB occlusion
rate between quartiles II and III (p ¼ 0.80). Thus,
quartile I was determined to be the low-risk group
(quartile I, score: 0 to 2); quartiles II and III were
combined into an intermediate-risk group (quartiles II
and III, score: 3-9); and quartile IV was the high-risk
group (quartile IV, score: 10 to 43) (Table 5).
For the 401 lesions included in the validation
cohort, the RESOLVEmodel displayed good prognostic
accuracy, with a C-statistic of 0.81 (95% CI: 0.73
to 0.89; HL p ¼ 0.77) (Figure 3B). The RESOLVE score
also displayed good prognostic accuracy, with a
C-statistic of 0.77 (95% CI: 0.69 to 0.86; HL p ¼ 0.58)
TABLE 3 Quantitative Coronary Angiographic Analysis
No SB Occlusion
(n ¼ 1,483)
SB Occlusion
(n ¼ 118) p Value
Proximal MV
Reference diameter (mm) 3.0  0.5 3.1  0.5 0.049
Diameter stenosis (%) 55.3  28.0 63.8  24.9 <0.001
Lesion length (mm) 13.2  7.7 12.8  7.7 0.61
Distal MV
Reference diameter (mm) 2.6  0.48 2.8  0.5 0.001
Diameter stenosis (%) 52.4  25.9 56.1  25.3 0.14
Lesion length (mm) 9.4  7.0 9.5  7.2 0.99
SB
Reference diameter (mm) 2.0  0.39 1.8  0.3 <0.001
Diameter stenosis (%) 31.2  20.1 44.8  24.9 <0.001
Lesion length (mm) 3.5  2.4 3.5  2.2 0.70
Bifurcation core
Reference diameter (mm) 2.9  0.5 3.0  0.5 0.02
Diameter stenosis (%) 33.4  27.9 50.9  29.0 <0.001
Lesion length (mm) 3.0  1.67 3.4  1.49 0.01
Bifurcation angle () 53.0  20.6 64.5  23.0 <0.001
Diameter ratio between MV/SB 1.4  0.3 1.6  0.3 <0.001
The most severe diameter stenosis of MV (%) 73.8  16.5 77.9  15.2 0.009
Total lesion length of MV (mm) 25.6  10.2 25.7  10.0 0.98
Diameter stenosis of SB before MV stenting (%) 32.0  18.9 47.9  28.4 <0.001
Diameter stenosis of MV before MV stenting (%) 52.3  15.6 54.7  14.3 0.10
Values are mean  SD.
Abbreviations as in Table 2.
TABLE 2 Continued
No SB Occlusion
(n ¼ 1,483)
SB Occlusion
(n ¼ 118) p Value
Procedural characteristics
MV
Dissection before MV stenting 20 (1.4) 6 (5.1) 0.01
TIMI ﬂow grade before MV stenting <0.001
TIMI 0 1 (0.1) 0 (0)
TIMI 1 6 (0.4) 4 (3.4)
TIMI 2 11 (0.7) 4 (3.4)
TIMI 3 1,465 (98.8) 110 (93.2)
SB
SB pre-dilation 230 (15.5) 10 (8.5) 0.05
TIMI ﬂow grade before MV stenting <0.001
TIMI 0 0 (0) 7 (5.9)
TIMI 1 2 (0.1) 10 (8.5)
TIMI 2 8 (0.5) 6 (5.1)
TIMI 3 1,473 (99.3) 95 (80.5)
Jailed wire in SB 425 (28.7) 19 (16.1) 0.005
Values are n (%).
LAD ¼ left anterior descending; LCX¼ left circumﬂex; MV ¼main vessel; OM¼ obtuse marginal branch; RCA¼
right coronary artery; SB ¼ side branch; TIMI ¼ Thrombolysis In Myocardial Infarction.
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43(Figure 3B). As shown in Table 5, SB occlusion rates in
the validation cohort increased signiﬁcantly across
different risk groups: 0.0% in the low-risk group, 3.8%
in the intermediate-risk group, and 19.8% in the high-
risk group (p < 0.001). We performed an additional
analysis to validate the performance of RESOLVE score
in the subset of patients in whom the jailed wire
technique was utilized (shown in Online Figure 1).
Although the C-statistic was slightly worse than that of
the original RESOLVE score, it was still predictive in
patients in whom the jailed wire technique was
utilized.
DISCUSSION
The major ﬁndings of this study are: 1) a novel risk
stratiﬁcation score system (the RESOLVE risk score)
consisting of 6 variables was developed; 2) the 6
variables independently predictive of adverse out-
comes included 5 angiographic variables and 1 novel
derived variable (diameter ratio of MV/SB); and
3) the RESOLVE score was able to accurately predict
the risk of SB occlusion in patients undergoing coro-
nary bifurcation intervention with good discrimi-
nation and calibration in both the derivation and
validation datasets.
The RESOLVE risk score was created speciﬁcally for
patients with coronary bifurcation disease undergo-
ing PCI. Bifurcations frequently contain a nonuniform
geometrical distribution of atherosclerotic plaque,
and the presence of a large plaque burden at the core
of the bifurcation has been demonstrated to be asso-
ciated with SB ostial deterioration and occlusion
during MV treatment, even if signiﬁcant disease in
the SB is absent at baseline (15). It is, therefore, not
surprising that plaque located at the same side of
the SB was an important correlate of SB occlusion.
Among other covariates included in the model, ar-
teries with lower TIMI ﬂow grade are more likely to
have thrombus or other complex lesion features, and
therefore, are more likely to have SB occlusion. Of
note, the diameter stenosis of the bifurcation core,
but neither the proximal nor the distal MV stenosis,
was independently predictive of SB occlusion. The
bifurcation core is the area most adjacent to SB,
and as such, a smaller diameter stenosis could be a
correlate of plaque shift during MV PCI. We also
found that the risk of SB occlusion increased as the
ratio of the diameter of MV/SB increased, which is
concordant with the results of previous studies (16).
The mechanism of SB occlusion is a question that
remains to be clariﬁed, although both plaque shift
and carina shift have been thought to be potential
mechanisms (17). Plaque shift seemed to explain mostof the predictors in the present study, which was in
consistent with a previous study (6). Future large
sample size studies using intraluminal imaging may
help to further clarify the actual mechanism of SB
FIGURE 3 ROC Curves for RESOLVE Model and Score
Receiver-operator characteristic (ROC) curves for the RESOLVE
model and score. (A) ROC curve based on developmental data-
set. Area under the curve (AUC) for the RESOLVE model was
0.80 (95% conﬁdence interval [CI]: 0.75 to 0.85) and AUC for
the RESOLVE score was 0.76 (95% CI: 0.71 to 0.82). (B) ROC
curve based on validation dataset. AUC for the RESOLVE model
was 0.81 (95% CI: 0.73 to 0.89) and AUC for the RESOLVE
score was 0.77 (95% CI: 0.69 to 0.86).
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44occlusion. Although previous studies have reported
that lesion length of SB was associated with SB oc-
clusion, in the present study, based on 1,545 consec-
utive patients with 1,601 bifurcation lesions, lesion
length of SB was not selected as an independent
predictor of SB occlusion after univariable and
multivariable analysis. In our study, we founddiameter stenosis of bifurcation core and SB were
independent predictors of SB occlusion. Neither the
MV nor SB lesion length was signiﬁcantly correlated
with SB occlusion. The severity of lesion rather than
the length of lesion seemed to be more predictive for
SB occlusion in our study. However, it is possible that
due to the relatively short length of SBs within the
current study, we may have lacked the ability to
detect lesion length as an independent predictor of
occlusion. Additional prospective clinical studies
with a broader range of SB lengths may further help
to clarify the question.
The effect of BA on the rate of SB occlusion during
PCI is controversial. Previous studies have reported
that smaller angle in coronary bifurcations predicted
higher SB compromise, restenosis, and major adverse
cardiovascular event rates based on small sample size
(16). In addition, Goto et al. (18) reported that BA was
not associated with SB compromise after MV stenting.
However, Dzavik et al. (19) found that BA >50 was an
independent predictor of major adverse cardiovas-
cular events after bifurcation crush stenting. In our
study, a wide BA predicted SB occlusion after MV
stenting. Part of the explanation was that bifurcations
with smaller BA were easier for ﬂow diversion into
the SB, and a BA that is too large might increase
the pressure drop and ﬂow resistance (20), thus
increasing the SB occlusion risk. Another potential
explanation was that increasing BA decreased wall
shear stress and increased oscillatory shear index
signiﬁcantly around the carina (21), which might in-
duce plaque proliferation at the bifurcation region
(22,23). Higher plaque volume in the bifurcation core
may contribute to the higher SB occlusion risk. Our
study found that lesions with high BA (BA $50) had
signiﬁcantly higher pre-procedural diameter stenosis
of bifurcation core (37.7  29.2% vs. 29.9  26.5%,
p < 0.001) as compared with lesions with low BA
(BA <50) (Online Appendix). In addition, lesions
with high BA (BA $50) had a signiﬁcantly lower
incidence of jailed wire in SB (22.7% vs. 32.2%, p <
0.001) compared with lesions with low BA (BA <50);
the inability to protect the SB may also contribute to
SB occlusion.
Compared with previous studies (6,9–11), the
strength of our study is that we have established
the RESOLVE risk score system as a risk stratiﬁca-
tion tool for SB occlusion in coronary bifurcation
intervention. Another strength of our study was
that the study was conducted in a consecutive
cohort of bifurcation patients, which could reﬂect
the real-world clinical practice. The RESOLVE risk
score, derived from a large cohort of patients un-
dergoing provisional bifurcation PCI, has excellent
TABLE 4 Scores Attributed to Each Variable
Risk Factor Level Point
Plaque distribution At the opposite
side of SB
0
At the same
side of SB
1
MV TIMI ﬂow grade before stenting TIMI 3 0
TIMI 2 6
TIMI 1 11
TIMI 0 17
Pre-procedural diameter stenosis
of bifurcation core (%)
<50 0
50–<70 2
$70 3
Bifurcation angle () <70 0
70–<90 4
$90 6
Diameter ratio between MV/SB <1.0 0
1.0–<1.5 2
1.5–<2.0 6
$2.0 9
Diameter stenosis of SB before
MV stenting (%)
<50 0
50–<70 4
70–<90 6
$90 7
Abbreviations as in Table 2.
TABLE 5 Frequency Distribution of SB Occlusion Across Different Risk Groups
Low-Risk
Group
(Quartile I)
Intermediate-Risk
Group
(Quartile II þ III)
High-Risk
Group
(Quartile IV) p Value
Range 0–2 3–9 $10
SB occlusion rate in training
dataset (n ¼ 1,200)
1/98 (1.0) 29/770 (3.8) 58/332 (17.5) <0.001
SB occlusion rate in validation
dataset (n ¼ 401)
0/47 (0) 9/239 (3.8) 21/85 (19.8) <0.001
Values are n/N (%).
SB ¼ side branch.
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45discriminative ability (C-statistic for this RESOLVE
risk model was 0.80 [95% CI: 0.75 to 0.85], and
the C-statistic for RESOLVE risk score was 0.76
[95% CI: 0.71 to 0.82]) that was slightly greater
than that described in a previous study (6). The
RESOLVE risk score system contains only 6 vari-
ables and is simple to calculate, but does include
QCA data, which may add to its discriminatory
capacity. Coronary angiography before stenting
may represent the most useful angiographic time
point for physicians to choose a bifurcation inter-
vention strategy.
STUDY LIMITATIONS. First, the RESOLVE risk score
was developed in consecutive patients enrolled at asingle center. Thus, although the discrimination of
the RESOLVE risk score was conﬁrmed in a separate
cohort of patients, its predictive accuracy of SB oc-
clusion in patients with coronary bifurcation disease
undergoing PCI should be further validated from a
different study dataset. Second, the extent of coro-
nary artery disease was determined by QCA. Although
QCA may be time-consuming and/or not immediately
available, it provides a more objective determination
of the extent and severity of coronary artery disease
than visual assessment (24). Therefore, scores that
use QCA may be more reproducible than those based
only on visual estimation of angiographic variables.
CONCLUSIONS
The RESOLVE risk score is a novel and simple risk
stratiﬁcation tool speciﬁcally developed for patients
with coronary bifurcation disease undergoing PCI.
The RESOLVE risk score is accurately predictive in
both discrimination and calibration, and further
validation of its performance in other patient pop-
ulations is warranted.
REPRINT REQUESTS AND CORRESPONDENCE: Mr.
Bo Xu or Dr. Yuejin Yang, Fuwai Hospital, National
Center for Cardiovascular Diseases, A 167, Beilishi
Road, Xicheng District, Beijing, 100037, China.
E-mail: bxu@citmd.com OR yangyjfw@126.com.RE F E RENCE S1. Maeng M, Holm NR, Erglis A, et al. Long-term
results after simple versus complex stenting of
coronary artery bifurcation lesions: Nordic Bifur-
cation Study 5-year follow-up results. J Am Coll
Cardiol 2013;62:30–4.
2. Ferenc M, Gick M, Kienzle RP, et al. Randomized
trial on routine vs. provisional T-stenting in the
treatment of de novo coronary bifurcation lesions.
Eur Heart J 2008;29:2859–67.
3. Hildick-Smith D, de Belder AJ, Cooter N,
et al. Randomized trial of simple versus complex
drug-eluting stenting for bifurcation lesions: theBritish Bifurcation Coronary Study: old, new, and
evolving strategies. Circulation 2010;121:
1235–43.
4. Gwon HC, Choi SH, Song YB, et al. Long-term
clinical results and predictors of adverse outcomes
after drug-eluting stent implantation for bifurca-
tion lesions in a real-world practice: the COBIS
(Coronary Bifurcation Stenting) registry. Circ J
2010;74:2322–8.
5. Muramatsu T, Onuma Y, Garcia-Garcia HM, et al.
Incidence and short-term clinical outcomes of
small side branch occlusion after implantation ofan everolimus-eluting bioresorbable vascular
scaffold: an interim report of 435 patients in the
ABSORB-EXTEND single-arm trial in comparison
with an everolimus-eluting metallic stent in the
SPIRIT ﬁrst and II trials. J Am Coll Cardiol Intv
2013;6:247–57.
6. Hahn JY, Chun WJ, Kim JH, et al. Predictors and
outcomes of side branch occlusion after main
vessel stenting in coronary bifurcation lesions:
results from the COBIS II Registry (COronary
BIfurcation Stenting). J Am Coll Cardiol 2013;62:
1654–9.
Dou et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 , 2 0 1 5
Risk Prediction of Side Branch Occlusion J A N U A R Y 2 0 1 5 : 3 9 – 4 6
467. Latib A, Colombo A. Bifurcation disease: what
do we know, what should we do? J Am Coll Cardiol
Intv 2008;1:218–26.
8. Girasis C, Farooq V, Diletti R, et al. Impact of
3-dimensional bifurcation angle on 5-year
outcome of patients after percutaneous coronary
intervention for left main coronary artery disease:
a substudy of the SYNTAX trial (synergy between
percutaneous coronary intervention with taxus
and cardiac surgery). J Am Coll Cardiol Intv 2013;
6:1250–60.
9. Hayashi S, Tohyama S, Shindo T, et al.
Risk of side branch occlusion after coronary
Palmaz-Schatz stenting. J Cardiol 1997;29:
261–6.
10. Aliabadi D, Tilli FV, Bowers TR, et al. Incidence
and angiographic predictors of side branch occlu-
sion following high-pressure intracoronary stent-
ing. Am J Cardiol 1997;80:994–7.
11. Kralev S, Poerner TC, Basorth D, et al. Side
branch occlusion after coronary stent implantation
in patients presenting with ST-elevation myocar-
dial infarction: clinical impact and angiographic
predictors. Am Heart J 2006;151:153–7.
12. Louvard Y, Medina A, Stankovic G. Deﬁni-
tion and classiﬁcation of bifurcation lesions
and treatments. EuroIntervention 2010;6
Suppl J:J31–5.
13. Lansky AJ, Dangas G, Mehran R, et al. Quan-
titative angiographic methods for appropriate
end-point analysis, edge-effect evaluation, andprediction of recurrent restenosis after coronary
brachytherapy with gamma irradiation. J Am Coll
Cardiol 2002;39:274–80.
14. Janssen JP, Rares A, Tuinenburg JC, et al. New
approaches for the assessment of vessel sizes in
quantitative (cardio-)vascular X-ray analysis. Int J
Cardiovasc Imaging 2010;26:259–71.
15. Costa RA, Costa MA, Moussa ID. Bifurcation
lesion morphology and intravascular ultrasound
assessment. Int J Cardiovasc Imaging 2011;27:
189–96.
16. Gil RJ, Vassilev D, Formuszewicz R, et al.
The carina angle-new geometrical parameter
associated with periprocedural side branch
compromise and the long-term results in coronary
bifurcation lesions with main vessel stenting only.
J Interv Cardiol 2009;22:E1–10.
17. Koo BK, Waseda K, Kang HJ, et al. Anatomic
and functional evaluation of bifurcation lesions
undergoing percutaneous coronary intervention.
Circ Cardiovasc Interv 2010;3:113–9.
18. Goto Y, Kawasaki T, Koga N, et al. Plaque
distribution patterns in left main trunk bi-
furcations: prediction of branch vessel compro-
mise by multidetector row computed topography
after percutaneous coronary intervention.
EuroIntervention 2012;8:708–16.
19. Dzavik V, Kharbanda R, Ivanov J, et al. Pre-
dictors of long-term outcome after crush stenting
of coronary bifurcation lesions: importance of the
bifurcation angle. Am Heart J 2006;152:762–9.20. Sayed Razavi M, Shirani E. Development of
a general method for designing microvascular
networks using distribution of wall shear stress.
J Biomech 2013;46:2303–9.
21. Huo Y, Finet G, Lefevre T, et al. Which
diameter and angle rule provides optimal ﬂow
patterns in a coronary bifurcation? J Biomech
2012;45:1273–9.
22. Kimura BJ, Russo RJ, Bhargava V, et al.
Atheroma morphology and distribution in
proximal left anterior descending coronary
artery: in vivo observations. J Am Coll Cardiol
1996;27:825–31.
23. Rodriguez-Granillo GA, Garcia-Garcia HM,
Wentzel J, et al. Plaque composition and its
relationship with acknowledged shear stress pat-
terns in coronary arteries. J Am Coll Cardiol 2006;
47:884–5.
24. Beauman GJ, Vogel RA. Accuracy of individual
and panel visual interpretations of coronary arte-
riograms: implications for clinical decisions. J Am
Coll Cardiol 1990;16:108–13.KEY WORDS coronary bifurcation lesion,
intervention strategy, risk prediction,
score system, side branch occlusion
APPENDIX For supplemental methods,
tables, and ﬁgures, please see the online
version of this article.
